Eleutherococcus (Siberian ginseng)
In short
Summary of findings for quick reference
Eleuthero is the root of a prickly East Asian shrub. Eleutherococcus senticosus belongs to the Araliaceae family and has different characteristic constituents from Panax ginseng. In Chinese medicine the root is called Ci Wu Jia. Soviet researchers seeking a more plentiful substitute for ginseng in the 1950s and 1960s made it the model adaptogen, a substance intended to increase resistance to stress. Older collective plant names leave the earlier Chinese history of this particular species uncertain.
In its 2014 monograph, the official text on use and safety, the European Medicines Agency (EMA) recognises the traditional use of eleuthero for fatigue and weakness. That recognition rests on decades of use and requires no efficacy trials. On that basis, products can be registered as traditional herbal medicines. Commission E and the WHO also describe the root as a tonic.
Human trials give mixed results. In 96 chronically fatigued adults, the difference between eleuthero and placebo was not statistically significant. In 2013 a root extract gave no statistically significant added benefit alongside stress management training after eight weeks. An endurance trial in nine men was positive, while five rigorous sports studies in an earlier review found no benefit. Laboratory findings in immune cells do not establish a benefit in people. Limit use to two months. See a doctor if symptoms last longer than two weeks or worsen.
Clinical evidence ↔ Historical significanceWe display two separate evidence categories: clinical evidence from modern trials and historical significance from documented healing tradition. Both are valuable, but they answer different questions.Read more
In every encyclopedia entry we evaluate two distinct categories of evidence. Clinical evidence as used in trials meets a narrower but scientifically essential bar. At the same time, the hundreds of thousands of plant species worldwide have only partially been captured and tested in modern studies.
Alongside the trial picture our researchers compile a comprehensive overview of where and since when a plant has been used across different traditions of natural medicine. When a plant has been used as a medicinal plant in many cultures across many generations, that historical significance deserves to be visible too.
Our position: a truly informative overview emerges only when both categories sit side by side. We communicate transparently what counts as what.
Overview
Eleutherococcus senticosus, known in traditional Chinese medicine as Ci Wu Jia (刺五加) and commonly called eleuthero, is a prickly deciduous shrub of the Araliaceae family. It grows in the temperate forests of the Russian Far East, China, Korea and Japan. The dried roots and rhizomes are used. Traditionally the root is a strengthening tonic, but its worldwide reputation comes from Soviet adaptogen research of the 1950s and 1960s. The species name senticosus is Latin for full of thorns and refers to the prickles on the shoots.
Despite the name Siberian ginseng, eleuthero is not true ginseng. It belongs to the same family as Panax ginseng but to a different genus, and its characteristic constituents are the eleutherosides. The content of eleutherosides B and E is used to check the quality of root preparations. In its 2014 monograph, the European Medicines Agency (EMA) lists eleuthero as a traditional herbal medicine for fatigue and weakness. A product sold as Siberian ginseng or eleuthero cannot be swapped for a Panax ginseng product.
History
In China the root is known as Ci Wu Jia and is listed in today's Chinese Pharmacopoeia. Modern reviews trace it back to the Shennong Bencao Jing, the classic Chinese herbal usually dated between 100 BC and AD 200. Davydov and Krikorian counter that old Chinese plant names can rarely be tied to one species with certainty, and they describe the medicinal use of this particular species as rather recent. How far back the Chinese tradition for Eleutherococcus senticosus really goes therefore remains open.
Davydov and Krikorian describe an early botanical collection in Beijing. Between 1830 and 1841 Porfiry Kirilov, physician to the eleventh Russian Ecclesiastical Mission, collected the shrub and brought material to St Petersburg in 1842. Ruprecht and Carl Maximowicz of the Imperial Botanical Garden described it later. Maximowicz also raised it from seed sent back from a trip to Manchuria. This collection history does not date medicinal use. The genus name joins the Greek eleutheros, free, and kokkos, seed. Russian names include nedotroga, the untouchable, and devil’s bush.
Eleuthero owes its international reputation to Soviet research. True ginseng was scarce in the Far East, and a good root takes at least six years to grow. From the late 1940s, researchers at the Academy of Sciences in Vladivostok studied substances that raise nonspecific resistance and searched the Araliaceae family for a substitute. The prickly shrub grew plentifully and was easier to cultivate. The EMA’s 2014 assessment traces Israel Brekhman’s publications to 1960. It records approval of a root extract for clinical use as a stimulant in 1962, a recommendation for the Soviet space programme in 1966 and Brekhman’s 1968 book Eleutherococcus. It puts the number of papers since his first article at more than a thousand.
In their 2025 review, Patyra and colleagues trace the term adaptogen to the Russian toxicologist N. Lazarev in 1958. It describes substances intended to increase resistance to stress. The review attributes three criteria to Brekhman and I. V. Dardymov in 1969. An adaptogen should be harmless, act nonspecifically against physical, chemical and biological stresses, and normalise disturbed functions regardless of the direction of change. Alongside eleuthero they list ginseng, roseroot and schisandra. Accounts of Soviet elite athletes and their coaches accompanied the preparations’ spread to Western Europe. These historical criteria do not establish the safety of a modern product.
German Commission E described eleuthero as a tonic for fatigue, declining work and concentration, and convalescence. The official BVL bibliography dates its monograph to 17 January 1991. The EMA issued its first monograph in 2008 and reassessed traditional use for fatigue and weakness in 2014, removing the earlier high blood pressure contraindication. Its 2014 report lists tea, powder and extracts, including sweet-wine extracts, one flavoured with wormwood. It dates the US trade name Siberian ginseng to about 1971. A 2002 law reserved ginseng for the genus Panax.
Mechanism
Eleuthero root contains several glycosides, lignans, coumarins and polysaccharides. Eleutheroside B, a phenylpropanoid glycoside called syringin, and eleutheroside E, a lignan glycoside, are important quality-control markers. These differ from the ginsenosides of true ginseng. Defined marker content helps characterise preparations but does not by itself establish clinical efficacy.
Research mainly examines the stress response, the hormonal interaction between brain and adrenal glands known as the hypothalamic-pituitary-adrenal axis. Most findings come from cell and animal studies. In Schaffler and colleagues’ trial, the morning cortisol rise was blunted after two weeks. The three groups, including training alone, did not differ significantly. Any separate contribution from the extract remains uncertain, as do the active constituents in people. In a cell study, the whole extract acted differently from isolated eleutherosides B and E. Chemical differences from Panax ginseng do not rule out shared cellular targets.
In Hartz and colleagues’ 2004 Iowa trial, 96 adults with unexplained fatigue lasting at least six months were randomised to a standardised root extract or placebo. At two months fatigue had eased markedly in both groups, but the difference was not statistically significant. In 2013 Schaffler and colleagues randomised another 144 adults with stress-related exhaustion to root extract, stress management training or both. The trial was open. At eight weeks, the combination had no statistically significant advantage over training alone. A small trial in 20 older people found better social-functioning scores with eleuthero after four weeks. That difference did not persist at eight weeks.
The picture is similar in sport. In 2010, Kuo and colleagues gave nine male recreational athletes 800 mg of eleuthero a day and a placebo for eight weeks each, double blind and in random order. After the eleuthero phase, peak oxygen uptake was 12 percent higher and they lasted 23 percent longer on the exercise bike. A 2005 review by Goulet and Dionne concluded, however, that the positive sports studies had serious methodological flaws, while five rigorous studies showed no benefit. Older Soviet studies in athletes and workers are numerous, and Brekhman reported in 1968 on experiments with more than 1,500 athletes. They are methodologically uneven and mostly fall short of current standards for controlled trials.
The EMA describes traditional use for fatigue and weakness. Performance and immunity are not indications in its monograph. The assessment concerns herbal medicines and does not authorise health claims for food supplements. In the larger trials, added benefit over placebo or training was not statistically significant. Favourable results from smaller studies remain limited to the people and preparations studied.
Evidence
| Outcome | Class | Grade | Effect | Studies | Refs |
|---|---|---|---|---|---|
| Fatigue and weakness (asthenia), traditional useThe EMA describes traditional use for fatigue and weakness on the basis of long-standing use. In Hartz’s 2004 placebo-controlled trial in 96 chronically fatigued adults, fatigue eased markedly in both groups. The difference between eleuthero and placebo was not statistically significant. In 2013 Schaffler and colleagues found no statistically significant added benefit from a root extract alongside stress management training after eight weeks.Adults who feel tired or are recovering from an illness | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Traditional use | [1][2] | |
| Physical and exercise performanceIn a double-blind trial in nine recreational athletes, eight weeks of eleuthero improved endurance and oxygen uptake (Kuo 2010). A 2005 review, however, found no endurance benefit in the five methodologically sound studies, while the positive reports had serious flaws. A performance gain is therefore not established.Recreationally active adults in small randomised trials | EmergingEmerging research. Early small trials suggest an effect but await replication. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Mixed results | [3] | |
| Changes in the immune system in cell and animal studiesLaboratory and animal studies describe changes in immune measures. In Steinmann and colleagues' cell study, the whole ethanolic extract increased production of the messengers interleukin-1 and interleukin-6, while isolated eleutherosides B and E did not. A benefit for the immune system has not been shown in people.Cell and animal studies | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | IEvidence quality grade I (Insufficient). Not enough evidence to draw a conclusion. More research needed. This is an evidence rating, not a product endorsement. | Laboratory findings only | [4] | |
| Tonifying use in Traditional Chinese Medicine (Ci Wu Jia)Chinese medicine calls the root Ci Wu Jia and treats it as a tonic that nourishes qi, strengthens the spleen and calms the mind. This description comes from the teaching of Chinese medicine, not from human studies, and it does not carry over to the history of true ginseng.Adults, in the setting of traditional Chinese medicine | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | IEvidence quality grade I (Insufficient). Not enough evidence to draw a conclusion. More research needed. This is an evidence rating, not a product endorsement. | Traditional use |
The studies that matter.
In Iowa, 96 adults with unexplained fatigue lasting at least six months were randomised to a standardised eleuthero extract or placebo. At two months, 76 provided follow-up information. Fatigue eased markedly in both groups, with no statistically significant difference. A benefit appeared among less severely fatigued participants, without adjustment for multiple comparisons. A reliable benefit for the full group studied remains unproven.
Hartz AJ, Bentler S, Noyes R, Hoehns J, Logemann C, Sinift S, Butani Y, Wang W, Brake K, Ernst M, Kautzman H. Hartz AJ, Bentler S, Noyes R, et al. Randomized controlled trial of Siberian ginseng for chronic fatigue. Psychol Med. 2004;34(1):51-61 doi:10.1017/s0033291703008791144 adults with stress-related fatigue and reduced work capacity were randomised to three groups. For eight weeks they received 120 mg of dry root extract daily, a two-day professional stress management course, or both. Almost every measure improved, and the combination significantly outperformed extract alone for mental fatigue and restlessness. It had no statistically significant advantage over training alone at eight weeks. The open trial, in which everyone knew their treatment, described the extract’s added benefit as negligible at best and all three treatments as well tolerated.
Schaffler K, Wolf OT, Burkart M. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study doi:10.1055/s-0033-1347178The 2005 review examined eleuthero and endurance exercise. Three studies reported marked gains in fitness, fat metabolism and endurance, but each had serious design flaws. Five rigorously conducted studies found no benefit at doses up to 1,000 to 1,200 mg daily for one to six weeks, during exercise lasting six to 120 minutes. The authors concluded that supplementation offered no advantage for those amounts and exercise conditions.
Goulet ED, Dionne IJ. Goulet ED, Dionne IJ. Assessment of the effects of eleutherococcus senticosus on endurance performance. Int J Sport Nutr Exerc Metab. 2005;15(1):75-83 doi:10.1123/ijsnem.15.1.75Nine recreationally trained male students took 800 mg of eleuthero or starch placebo daily for eight weeks each, double blind and in random order, with a four-week washout. After the eleuthero phase, peak oxygen uptake was 12 percent higher and cycling endurance 23 percent longer. After 30 minutes of cycling, their blood contained more free fatty acids and less glucose. This favourable finding comes from a very small trial in nine men.
Kuo J, Chen KWC, Cheng IS, Tsai PH, Lu YJ, Lee NY. The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human doi:10.4077/cjp.2010.amk018Twelve healthy volunteers took 485 mg of a standardised extract twice daily for 14 days. Before and after treatment, test medicines showed the activity of the liver enzymes CYP2D6 and CYP3A4. Changes in either pathway were not statistically significant. The authors considered interactions through these routes unlikely at usual doses. This small study covers neither every preparation nor possible digoxin interactions.
Donovan JL, DeVane CL, Chavin KD, Taylor RM, Markowitz JS. Donovan JL, DeVane CL, Chavin KD, Taylor RM, Markowitz JS. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos. 2003;31(5):519-22 doi:10.1124/dmd.31.5.519
Usage
Forms and preparation
Eleuthero is sold as comminuted root for tea, as powder, as tincture and as liquid or dry extracts, also in capsules and tablets. For tea, pour boiling water over the comminuted root. The 2014 EMA assessment also lists sweet-wine extracts, including one flavoured with wormwood. Extracts differ in their ratio of root to extract and in the solvent used to draw out the constituents. Findings for a particular extract therefore cannot simply be applied to tea or another product. Because eleuthero can disturb sleep, the morning is the best time to take it. Whether to take it with food is in the product instructions. When you switch products, compare the dose and also how much root went into how much extract and what it was extracted with. Eleutheroside B and E content alone does not make two products equivalent.
Dosage
The EMA sets doses by preparation. For tea it gives 0.5 to 4 grams of comminuted root daily, infused in a total of 150 millilitres of boiling water and divided into one to three doses. For root powder the daily amount is 0.75 to 3 grams. For a 1:1 liquid extract, where one part of root gives one part of extract, made with 30 to 40 percent ethanol, it gives 2 to 3 millilitres daily, and for a 1:5 tincture made with 40 percent ethanol, 10 to 15 millilitres. Ethanolic dry extracts are dosed to correspond to 0.5 to 4 grams of dried root, an aqueous dry extract at 90 to 180 milligrams. For the two extracts made with sweet wine it gives 30 millilitres a day at a ratio of 1:11.3, and 25 to 33 grams at 1:20. One milligram dose for all extracts therefore does not exist. Follow your product's instructions. Limit use to two months. If fatigue or weakness lasts more than two weeks or worsens, seek medical advice about the cause. Follow the preparation’s dosage instructions. The EMA monograph does not specify a fixed break for repeated courses.
Special populations
The EMA advises against eleuthero in pregnancy and while breastfeeding because adequate safety data are lacking. No fertility data are available. Eleuthero is not recommended for children under 12, because adequate data are lacking. The doses in the EMA monograph apply to adolescents from 12, adults and older people. If you have high blood pressure or heart disease, talk to your doctor before you start. The EMA removed high blood pressure as a contraindication in 2014, because it found the previous justification insufficient after reassessment. A racing heart remains a possible side effect. If you take digoxin, speak to your doctor before starting. Some products distort the measurement of digoxin levels. In a cell study an extract also inhibited a digoxin transporter. The 2014 EMA assessment found no confirming human investigations. Ethanol-containing tinctures and extracts require appropriate alcohol warnings. The monograph’s 1:1 liquid extract is made with 30 to 40 percent ethanol, while other extracts use sweet wine. Check the alcohol content and package leaflet, especially if you should not or do not want to drink alcohol.
Safety
Drug interactions
The 2014 EMA monograph lists no reported interactions with medicines. In a study in 12 healthy volunteers, changes in the CYP2D6 and CYP3A4 pathways after two weeks of eleuthero extract were not statistically significant. These liver enzymes break down many medicines. Safety for every combination remains uncertain. Digoxin: in a 74-year-old man, the measured digoxin level rose twice while he took a product sold as Siberian ginseng and fell again after he stopped. Whether the product really contained eleuthero is unclear. Laboratory tests show that some products distort certain digoxin assays, upwards or downwards. In a cell study an extract also inhibited the transporter P-glycoprotein, involved in digoxin transport. The 2014 EMA assessment found no confirming human investigations. Other medicines use the same transporter, so their blood levels could change too. In a small trial in 20 older people taking digitalis, the difference in blood digitalis levels after eight weeks was not statistically significant. If you take digoxin, tell your doctor before you start eleuthero. Caffeine, sleeping medicines and diabetes medicines: reliable human data are lacking. If you take medicines regularly, talk to your doctor or pharmacist before you start.
Contraindications
Hypersensitivity to eleuthero: do not use any preparation of it. It is the only contraindication in the EMA monograph. Children under 12: not recommended, because there are not enough data for this age group. Pregnancy and breastfeeding: not recommended because adequate safety data are lacking. High blood pressure and heart disease: the EMA removed high blood pressure as a contraindication in 2014. The older 2002 WHO monograph advises against use at blood pressure above 180/90 mmHg. A racing heart remains a possible side effect. If you have high blood pressure or heart disease, consult your doctor before use.
Side effects
The EMA monograph lists insomnia, irritability, a racing heart and headache. How often they occur is not known. The EMA assessment warns about insomnia when it is taken close to bedtime. In the two-month trial in 96 chronically fatigued adults, side effects such as nervousness and headache were reported by 24 percent on eleuthero and 28 percent on placebo. Breast tenderness and uterine bleeding were more frequent on eleuthero (14 against 4 percent), a difference that was not statistically significant. Soviet studies from 1966 reported isolated cases of heart rhythm disturbances, palpitations, pain in the heart region and raised blood pressure in heart patients, partly at high doses. In another study, high doses brought insomnia, irritability, melancholy and anxiety. If other complaints appear, ask your doctor or pharmacist.
Look-alikes
Similar plants and look-alikes
Panax ginseng (true ginseng)
Eleutherococcus and Panax ginseng belong to the Araliaceae family but to different genera. Eleuthero is a prickly shrub, true ginseng a low herbaceous perennial without woody shoots and with red fruit. Eleutherosides characterise eleuthero and ginsenosides true ginseng. The EMA treats them in separate monographs. The name Siberian ginseng encourages confusion. Check for Eleutherococcus senticosus and reliable quality control when buying, as a trade name does not guarantee the contents.
Read the entry: GinsengFAQs
Is Siberian ginseng the same as true ginseng (Panax ginseng)?
Eleuthero and true ginseng are different plants. Eleutherococcus senticosus belongs to the Araliaceae family like Panax ginseng, but to a different genus. Eleutherosides characterise eleuthero and ginsenosides true ginseng. Chinese medicine names them Ci Wu Jia and Ren Shen, and the EMA treats them in separate monographs. Since 2002, US law has reserved the name ginseng for the genus Panax. A trade name alone does not guarantee a product’s identity. Check the botanical name and reliable quality control.
What are eleutherosides?
Eleutherosides are a chemically mixed group of eleuthero constituents, named after the plant. The two most important are eleutheroside B, also called syringin, a phenylpropanoid glycoside, and eleutheroside E, a lignan glycoside. In a glycoside, sugar units are bound to another part of the molecule. B and E serve as chemical markers, and their content is measured to check the quality of root preparations. Roots dug in spring or autumn contain the most. A high content, however, says nothing about whether a product works or matches another extract. Eleutherosides and the ginsenosides of true ginseng are different substances.
What time of day is best for eleuthero?
Follow the instructions for your product. Eleuthero can disturb sleep, especially when taken close to bedtime, so the morning is a good time to take it. The EMA allows the daily dose to be split into one to three doses. If you have heart disease, talk to your doctor before you start.
How long can I take eleuthero without a break?
Two months at most, according to the EMA monograph. If fatigue or weakness lasts longer than two weeks during use or gets worse, have the cause checked by a doctor. The EMA sets no fixed break before a new course. The idea of courses comes from older advice summarised in the EMA assessment report. Russian schemes used courses of 25 to 30 days with one to two weeks off, and Commission E allowed up to three months. For products based on the EMA monograph, the two-month limit applies.
Does eleuthero improve sports performance?
Results are mixed. Soviet coaches are said to have given eleuthero to elite athletes. A small 2010 trial in nine recreational athletes found 23 percent greater cycling endurance after eight weeks. A 2005 review judged the positive studies seriously flawed. Five rigorously conducted studies found no benefit at doses up to 1,200 mg daily for one to six weeks. A reliable performance gain remains unproven.
14 sources.
- European Medicines Agency, Committee on Herbal Medicinal Products. Community herbal monograph on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix. 2014. Source
- Schaffler K, Wolf OT, Burkart M. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study. 2013. doi:10.1055/s-0033-1347178
- Kuo J, Chen KWC, Cheng IS, Tsai PH, Lu YJ, Lee NY. The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human. 2010. doi:10.4077/cjp.2010.amk018
- Steinmann GG, Esperester A, Joller P. Immunopharmacological in vitro effects of Eleutherococcus senticosus extracts. 2001. doi:10.1055/s-0031-1300006
- Dasgupta A, Wu S, Actor J, Olsen M, Wells A, Datta P. Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays. Significant variation in digoxin-like immunoreactivity among commercial ginsengs. 2003. doi:10.1309/34BJ-ECP7-UK6F-H13V
- Hartz AJ, Bentler S, Noyes R, Hoehns J, Logemann C, Sinift S, Butani Y, Wang W, Brake K, Ernst M, Kautzman H. Hartz AJ, Bentler S, Noyes R, et al. Randomized controlled trial of Siberian ginseng for chronic fatigue. Psychol Med. 2004;34(1):51-61. 2004. doi:10.1017/s0033291703008791
- Goulet ED, Dionne IJ. Goulet ED, Dionne IJ. Assessment of the effects of eleutherococcus senticosus on endurance performance. Int J Sport Nutr Exerc Metab. 2005;15(1):75-83. 2005. doi:10.1123/ijsnem.15.1.75
- Donovan JL, DeVane CL, Chavin KD, Taylor RM, Markowitz JS. Donovan JL, DeVane CL, Chavin KD, Taylor RM, Markowitz JS. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos. 2003;31(5):519-22. 2003. doi:10.1124/dmd.31.5.519
- McRae S. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ. 1996;155(3):293-5. 1996. PMID:8705908
- Cicero AF, Derosa G, Brillante R, Bernardi R, Nascetti S, Gaddi A. Cicero AF, Derosa G, Brillante R, et al. Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. Arch Gerontol Geriatr Suppl. 2004;(9):69-73. 2004. doi:10.1016/j.archger.2004.04.012
- European Medicines Agency, Committee on Herbal Medicinal Products. European Medicines Agency, HMPC. Assessment report on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix. EMA/HMPC/680615/2013, 25 March 2014. 2014. Source
- Davydov M, Krikorian AD. Davydov M, Krikorian AD. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. J Ethnopharmacol. 2000;72(3):345-93. 2000. doi:10.1016/s0378-8741(00)00181-1
- Patyra A, Kołtun-Jasion M, Kupniewska K, Parzonko A, Kiss AK. Patyra A, Kołtun-Jasion M, Kupniewska K, Parzonko A, Kiss AK. Eleutherococcus root: a comprehensive review of its phytochemistry and pharmacological potential in the context of its adaptogenic effect. Front Pharmacol. 2025;16:1683795. 2025. doi:10.3389/fphar.2025.1683795
- Markus Ruhsam and Peter M. Hollingsworth. Ruhsam M, Hollingsworth PM. Authentication of Eleutherococcus and Rhodiola herbal supplement products in the United Kingdom. Journal of Pharmaceutical and Biomedical Analysis 149, 403 to 409, 2018. Online 9 November 2017.. 2018. doi:10.1016/j.jpba.2017.11.025
Legal notice: The depiction of historical significance and traditional use is context within our encyclopedia and not a health claim for any product, not a treatment promise, and not a substitute for medical advice. What may be stated on product labels, product pages, or in advertising is governed by the applicable legal requirements.